Khng dng li bin gii quc gia, vi v th l "nh thuc ca th gii" hin cung ng 40% nhu cu thuc generic ti M, n c th xut khu cc dng thuc gim cn ny ra ton cu
Zepbound's December 2024 FDA approval for obstructive sleep apnea (OSA) opens an entirely new patient population, with tirzepatide now the first approved pharmacotherapy for OSA
With ongoing healthy habits and maintenance, results can be long-lasting
Deficient brain insulin signalling pathway in Alzheimers disease and diabetes
Similarly, many biotech companies enjoyed an obesity halo, offering benefits in the ability to attract funds, boost company valuations or command a deal premium as an acquisition target
For klow vs glow peptide comparison studies, use GLOW as the control arm and KLOW as the treatment arm to isolate KPVs contribution